Ocumension Therapeutics Sustainability Reports
Ocumension Therapeutics is an ophthalmic pharmaceutical platform company dedicated to identifying, developing, and commercializing first-or-best-in-class ophthalmic therapies. The company maintains a comprehensive portfolio covering both front- and back-of-the-eye diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 5493000USURI3SIL4Z85
FIGI: BBG00VSF0NN1
12 reports from 2020 to 2025
